Research Article

miR-657 Targets SRCIN1 via the Slug Pathway to Promote NSCLC Tumor Growth and EMT Induction

Figure 6

SRCIN1 inhibits NSCLC cell invasion and EMT induction. SRCIN1 was knocked down or overexpressed in A549 and NCI-H1650 cells. (a–c) SRCIN1 inhibited NSCLC cell invasion, as determined by plating cells treated as appropriate to the upper chamber of a Transwell insert, removing noninvasive cells after an appropriate period of time, and imaging the remaining cells (100x). Representative images are shown with corresponding quantification. (d) SRCIN1 suppressed the expression of EMT marker proteins in the indicated NSCLC cell lines, with GAPDH serving as a loading control. Outcomes are given as , . .
(a)
(b)
(c)
(d)